LWB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mesoblast Ltd

Watchlist Manager

Watchlist

Price: 1.3 EUR 9.38% Market Closed

Market Cap: €1.5B

M	Mesoblast Ltd F:LWB	AU
A	Ascendis Pharma A/S SWB:A71	DK
	Orell Fuessli AG SIX:OFN	CH
B	Build-A-Bear Workshop Inc F:FPW	US
	Ellington Financial Inc NYSE:EFC	US
	Budweiser Brewing Company APAC Ltd F:4BB1	HK
R	Ratch Group PCL SET:RATCH	TH
	Crescent Biopharma Inc F:C68	US

Profitability Summary

Mesoblast Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Negative 3Y Average Gross Margin

-50%

Gross Margin is Increasing

-270% > 58%

Negative Operating Margin

-112%

Negative 3Y Average Operating Margin

-786%

Operating Margin is Increasing

-836% > -112%

Negative Net Margin

-144%

Negative 3Y Average Net Margin

-1 020%

Net Margin is Increasing

-1 092% > -144%

Negative Free Cash Flow Margin

-93%

Negative 3Y Average Free Cash Flow Margin

-601%

Free Cash Flow Margin is Increasing

-847% > -93%

Negative ROE

-18%

Negative 3Y Average ROE

Negative 3Y Average ROIC